Product Details for: Takhzyro

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
300MG/2ML (150MG/ML)
Single-Dose Vial
351(a)
Takhzyro
Disc
002
Injection
Subcutaneous
300MG/2ML (150MG/ML)
Pre-Filled Syringe
351(a)
Takhzyro
Rx
003
Injection
Subcutaneous
150MG/1ML (150MG/ML)
Pre-Filled Syringe
351(a)
Takhzyro
Rx
Proper Name
lanadelumab-flyo
BLA Number
761090
Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Original Approval Date
August 23, 2018
Date of First Licensure
RETURN TO SEARCH RESULTS